Comments on: Benefits of Investing In Biotechnology http://www.wealthonwire.com/2009/03/benefits-of-investing-in-biotechnology.html Investment and Money Making Strategies Wed, 06 Oct 2010 22:19:11 +0000 hourly 1 http://wordpress.org/?v=3.0.1 By: Dovie Joplin http://www.wealthonwire.com/2009/03/benefits-of-investing-in-biotechnology.html/comment-page-1#comment-1226 Dovie Joplin Sun, 05 Sep 2010 09:21:01 +0000 http://www.wealthonwire.com/?p=52#comment-1226 Blogging like you do is such an art and you obviously have that skill here - I don't but I did find this that made me smile so maybe I can return the favour by making you smile too? to give you a you smile :) The buck doesn't even slow down here! Blogging like you do is such an art and you obviously have that skill here – I don’t but I did find this that made me smile so maybe I can return the favour by making you smile too?
to give you a you smile :) The buck doesn’t even slow down here!

]]> By: DC http://www.wealthonwire.com/2009/03/benefits-of-investing-in-biotechnology.html/comment-page-1#comment-378 DC Mon, 07 Dec 2009 03:39:42 +0000 http://www.wealthonwire.com/?p=52#comment-378 I agree, the biotech sector seems poised for significant growth. A perfect example of a small publibly traded company on the verge of BIG things is Advanced Cell Technology (OTC: ACTC). FDA review to commence Phase I clinical trials to treat blindness (Stargardt's disease) is underway - this will be the first ever FDA approved use of embryonic stem cells in humans. The company also has the largest portfolio of embryonic stem cell patents in the world. Furthermore, their methods of retrieving cell lines do not harm or destroy the embryo. I agree, the biotech sector seems poised for significant growth. A perfect example of a small publibly traded company on the verge of BIG things is Advanced Cell Technology (OTC: ACTC). FDA review to commence Phase I clinical trials to treat blindness (Stargardt’s disease) is underway – this will be the first ever FDA approved use of embryonic stem cells in humans. The company also has the largest portfolio of embryonic stem cell patents in the world. Furthermore, their methods of retrieving cell lines do not harm or destroy the embryo.

]]>